Inhibitory activity of diospyrin derivatives against Leishmania major parasites in vitro

Indian Journal of Pharmacology

Volumn 34, Issue 6, 2002, Pages 422-427

  Hazra, Banasri ^a   Golenser, J ^b   Nechemiya, O ^b   Bhattacharyya, S ^a   Azzam, T ^b   Domb, A ^b   Frankenburg, S ^c  

^a JADAVPUR UNIVERSITY   (India)

^b HEBREW UNIVERSITY   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Antiprotozoals; Cutaneous leishmaniasis; Naphthoquinone derivatives; Quinonoid compounds

Indexed keywords

ALKYL ETHER; DINAPHTHOQUINONOID; DIOSPYRIN; HYDROQUINONOID; LAWSONE; NAPHTHOQUINONOID; PLANT EXTRACT; THYMIDINE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASSAY; BARK; COMPARATIVE STUDY; CONTROLLED STUDY; DIOSPYROS MONTANA; DRUG DESIGN; DRUG EFFICACY; DRUG INHIBITION; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; GROWTH INHIBITION; IN VITRO STUDY; LEISHMANIA MAJOR; MEDICINAL PLANT; NONHUMAN; PARASITISM; PLANT STEM; PROMASTIGOTE; RADIOACTIVITY; SKIN LEISHMANIASIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 0036897829     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. WHO Division of Control of Parasitic Diseases. Accessed in 2001 Nov 8. http://www.who.int/emc/diseases/leish/leisdis1.html.
2. Abraham G, Leo YS, Singh M, Wong SY. A case report of visceral leishmaniasis in Singapore. Ann Acad Med Singapore 1997;26:713-716.
3. Alvar J, Jimenez M. Could infected drug users be potential Leishmania infantum reservoirs? AIDS 1994;8:854.
4. Thakur CP, Sinha GP, Pandey AK, Kumar N, Kumar P, Hassan SM, et al. Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line therapy? An observational study of 80 cases. Ann Trop Med Parasitol 1998;92:561-9.
5. Pecoul B, Chirac P, Trouiller P, Pinel J. Access to essential drugs in poor countries: A lost battle? J Am Med Assoc 1999;281:361-7.
6. Carvalho PB, Ferreira EI. Leishmaniasis phytotherapy. Nature's leadership against an ancient disease. Fitoterapia 2001;72:599-618.
7. Hogh B, Clarke PD, Camees D, North Durft HD, Overbosch D, Gunther M, et al. (Malarone International Study Team). Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: A randomised, double-blind study. Lancet 2000;356:1888-1894.
8. Hazra B, Saha AK, Ray R, Roy DK, Sur P, Banerjee A. Antiprotozoal activity of diospyrin towards Leishmania donovani. Trans Roy Soc Trop Med Hyg 1987;81:738-41.
9. Ray S, Hazra Mittra B, Das A, Majumder HK. Diospyrin, a bisnaphthoquinone: A novel inhibitor of type I DNA topoisomerase of Leishmania donovani. Mol Pharmacol 1998;54:994-9.
10. Hazra B, Pal S, Banerjee A. New diospyrin derivatives with improved tumour inhibitory activity towards Ehrlich ascites carcinoma. Med Sci Res 1994;22:351-3.
11. Yardley V, Snowdon D, Croft S, Hazra B. In vitro activity of diospyrin and derivatives against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. Phytother Res 1996;10:559-62.
12. Maeda H. Polymer-conjugated macromolecular drugs for tumor-specific targeting. In: Domb A, ed. Polymeric Site-Specific Pharmacotherapy. Chichester: John Wiley & Sons; 1994.
13. Zalipsky S, Gilon C, Zilkha A. Attachment of drugs to polyethylene glycols. Eur Polym J 1983;19:1177-83.
14. Hazra B, Sur P, Roy DK, Sur B, Banerjee A. Biological activity of diospyrin towards Ehrlich ascites carcinoma in Swiss A mice. Planta Med 1984;51:295-7.
15. Hazra B, Acharya S, Ghosh R, Patra A, Banerjee A. Ammonium metavanadate and perchloric acid: A novel reagent for dimerisation of naphthyl derivatives. Synth Commun 1999;29:1571-6.
16. Golenser J, Frankenburg S, Ehrenfreund T, Domb A. New treatment for hemoflagellates using amphotericin B-arabinogalactan conjugates. Antimicrobial Agents Chemother 1999;43:2209-14.
17. Powis G. Metabolism and reactions of quinonoid anticancer agents. Pharmacol Ther 1987;35:57-162.